A detailed history of Stevens Capital Management LP transactions in Amgen Inc stock. As of the latest transaction made, Stevens Capital Management LP holds 6,849 shares of AMGN stock, worth $2.13 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
6,849
Holding current value
$2.13 Million
% of portfolio
0.72%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$258.78 - $328.31 $1.77 Million - $2.25 Million
6,849 New
6,849 $1.79 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $607,026 - $717,797
2,833 New
2,833 $629,000
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $557,384 - $616,612
-2,542 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$198.88 - $227.6 $505,552 - $578,559
2,542 New
2,542 $572,000
Q2 2019

Jul 31, 2019

SELL
$166.7 - $195.41 $1.08 Million - $1.27 Million
-6,477 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$180.87 - $203.88 $1.17 Million - $1.32 Million
6,477 New
6,477 $1.23 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.